Immediate Impact

2 from Science/Nature 77 standout
Sub-graph 1 of 20

Citing Papers

A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
2024 Standout
Ulcerative Colitis in Adults
2023 Standout
1 intermediate paper

Works of Jürgen Rademaker being referenced

Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy
2018
Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
2005

Author Peers

Author Last Decade Papers Cites
Jürgen Rademaker 358 301 147 337 36 1.3k
Derek G. Lohan 745 241 47 315 49 1.4k
Richard Smart 411 180 39 81 48 1.1k
Gabe E. Owens 431 448 60 123 71 1.7k
N. Holzknecht 451 681 11 260 58 1.5k
Rick Feld 702 250 51 79 47 1.4k
Clare Roche 694 92 122 113 42 1.1k
Robert E. Bechtold 698 234 35 56 46 1.3k
John G. Murray 689 323 31 122 60 1.4k
Richard B. Towbin 668 206 62 137 43 1.4k
Vamsidhar R. Narra 559 481 73 98 35 1.2k

All Works

Loading papers...

Rankless by CCL
2026